Whereas the reduced sensitivity of cancer cells to chemotherapeutics induced by PER1 is detrimental because it compromises treatment efficacy, this effect might instead confer protection from toxic side effects of cytotoxic treatments in non-tumor cells with an intact circadian clock. This evidence concerns the gene PER1 and cancer.